Sommaire

Numéro précédent | Numéro suivant

• • ·The worldwide epidemic of multidrug-resistant tuberculosis

    Page :333

     
• • ·Environmental dissemination of NDM-1: time to act sensibly

    Page :334-335

    Mohd Shahid

    
• • ·Transmitted antiretroviral-resistant HIV: a coming anarchy?

    Page :336-337

    M-J Milloy, Evan Wood

    
• • ·Effect of selective decontamination on antibiotic resistance

    Page :337-338

    Jean-Louis Vincent, Frédérique Jacobs

    
• • ·Expert-proposed European strategies to monitor and control infection, antibiotic use, and resistance in health-care facilities

    Page :338-340

    Herman Goossens

    
• • ·Campaigns and continuity

    Page :340-341

    Sheldon Stone, Rose Gallagher, Julie Storr, Graham Tanner, on behalf of the Patient and Health Care Worker Alliance on Hand Hygiene †

    
• • ·Jeddah declaration on mass gatherings health

    Page :342-343

    Ziad A Memish, Abdullah A Alrabeeah

     
• • ·Errata

    Page :343

    
• • ·Errata

    Page :343

    
• • ·Clinical impact of antimicrobial resistance: design matters

    Page :344

    Hajo Grundmann, Marlieke de Kraker, Peter Davey

    
• • ·Clinical impact of antimicrobial resistance: design matters – Authors’ reply

    Page :344-345

    Marie-Laurence Lambert, Carl Suetens, Uwe Frank, Martin Wolkewitz

    
• • ·Schistosomiasis elimination

    Page :345

    Zhijie Zhang, Qingwu Jiang

    
• • ·Schistosomiasis elimination

    Page :346

    Alan Fenwick, Lorenzo Savioli

    
• • ·Schistosomiasis elimination – Authors’ reply

    Page :346-347

    Darren J Gray, Donald P McManus, Yuesheng Li, Gail M Williams, Robert Bergquist, Allen G Ross

    
• • ·HIV in Europe—no longer business as usual

    Page :348-349

    Kelly Morris

     
• • ·Surveillance, co-infection, resistance: tuberculosis in Europe

    Page :350-351

    Talha Burki

     
• • ·Infectious disease surveillance update

    Page :351

    Laura Benham

    Plan Plan
• • ·Vaccines and public health in Europe

    Page :352

    Raffaella Bosurgi

    Plan Plan  
• • ·Research brief

    Page :353

    Jane Bradbury

    Plan Plan  
• • ·Shame in the time of cholera

    Page :354

    Talha Burki

     
• • ·Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

    Page :355-362

    Timothy R Walsh, Janis Weeks, David M Livermore, Mark A Toleman

    Résumé Résumé Plan Plan  
• • ·Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Page :363-371

    Linda Wittkop, Huldrych F Günthard, Frank de Wolf, David Dunn, Alessandro Cozzi-Lepri, Andrea de Luca, Claudia Kücherer, Niels Obel, Viktor von Wyl, Bernard Masquelier, Christoph Stephan, Carlo Torti, Andrea Antinori, Federico García, Ali Judd, Kholoud Porter, Rodolphe Thiébaut, Hannah Castro, Ard I van Sighem, Céline Colin, Jesper Kjaer, Jens D Lundgren, Roger Paredes, Anton Pozniak, Bonaventura Clotet, Andrew Phillips, Deenan Pillay, Geneviève Chêne, for the EuroCoord-CHAIN study group †

    Résumé Résumé Plan Plan   
• • ·Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study

    Page :372-380

    Anne Marie GA de Smet, Jan AJW Kluytmans, Hetty EM Blok, Ellen M Mascini, Robin FJ Benus, Alexandra T Bernards, Ed J Kuijper, Maurine A Leverstein-van Hall, Arjan R Jansz, Bartelt M de Jongh, Gerard J van Asselt, Ine HME Frenay, Steven FT Thijsen, Simon NM Conijn, Jan A Kaan, Jan P Arends, Patrick DJ Sturm, Martin CJ Bootsma, Marc JM Bonten

    Résumé Résumé Plan Plan   
• • ·Metallo-β-lactamases: a last frontier for β-lactams?

    Page :381-393

    Giuseppe Cornaglia, Helen Giamarellou, Gian Maria Rossolini

    Résumé Résumé Plan Plan  
• • ·European guidelines on the clinical management of HIV-1 tropism testing

    Page :394-407

    LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, A De Luca, S Dressler, F Garcia, AM Geretti, T Klimkait, K Korn, B Masquelier, CF Perno, JM Schapiro, V Soriano, A Sönnerborg, A-M Vandamme, C Verhofstede, H Walter, M Zazzi, CAB Boucher, on behalf of the European Consensus Group on clinical management of tropism testing

    Résumé Résumé Plan Plan  
• • ·Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe

    Page :408-415

    Robert C Read, Giuseppe Cornaglia, Gunnar Kahlmeter, for the European Society of Clinical Microbiology and Infectious Diseases Professional Affairs Workshop group ‡

    Résumé Résumé Plan Plan  
• • ·Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia

    Page :416

    Arnaud Petit, Emmanuelle Levine, Ralph Epaud, Hubert Ducou Le Pointe, Adela Angoulvant